Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Atherosclerosis|February 7, 2018
Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: A cross-sectional study in chronic kidney disease patientsRyouta Maeba, Ken-Ichiro Kojima, Michito Nagura, et al.Journal of Lipid Research|March 12, 2014
Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic stateMegumi Nishimukai, Ryouta Maeba, Yuya Yamazaki, et al.Journal of Nutritional Science and Vitaminology|July 19, 2008
Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndromeRyouta Maeba, Hiroshi Hara, Hiroshi Ishikawa, et al.Journal of Atherosclerosis and Thrombosis|March 3, 2007
Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with agingRyouta Maeba, Tomomi Maeda, Makoto Kinoshita, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 19, 2015
Serum ethanolamine plasmalogens improve detection of cognitive impairment among elderly with high excretion levels of urinary myo-inositol: A cross-sectional studyRyouta Maeba, Atsushi Araki, Kenji Ishii, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 29, 2014
Serum choline plasmalogens-those with oleic acid in sn-2-are biomarkers for coronary artery diseaseMegumi Nishimukai, Ryouta Maeba, Akiko Ikuta, et al.Plos Genetics|March 6, 2013
Tysnd1 deficiency in mice interferes with the peroxisomal localization of PTS2 enzymes, causing lipid metabolic abnormalities and male infertilityYumi Mizuno, Yuichi Ninomiya, Yutaka Nakachi, et al.Pageof 2